AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discussion on the actions of a key figure at the FDA and its implications
The chapter delves into how Peter Marks at the FDA, a non-immunologist, has been making decisions on vaccine approvals and not always following scientists' advice, such as in the case of an Alzheimer's drug approval. It reveals the FDA's departure from its traditional regulatory role under Marks' leadership by actively promoting vaccines through videos.